Skip to content
Precision for Medicine
iStock-1148211446 iStock-1148211446

Multiplex Cytokine Assays with Luminex®

Cytokine levels can provide important insight into immunological events within a sample

At Precision, we utilize several technologies for cytokine analysis, including the Luminex platform for multiplex cytokine assays.

Luminex has advantages of high sensitivity while requiring low sample input and rapid analysis.

Build a complete understanding of the cytokines present in your sample

Our standard assays are designed to measure cytokines and chemokines released from chosen target cells, and we specialize in activated T-cell–based assays requiring same-day treatment and processing. All of our assays can be customized to detect specific groups of cytokines.

Advantages of Luminex assays

The Luminex platform uses fluorescently-labeled beads bound to capture antibodies to quantitatively detect a specific cytokine or other analyte of interest.

  • Multiplex up to 50-100 analytes
  • Wide dynamic range
  • High sensitivity
  • Low sample input
  • Limited matrix interference
  • Rapid analysis (a single 96-well plate run can be completed in just 60 minutes)
  • Commercially available panels and custom panels
  • An ideal choice for research and exploratory purposes

Our Luminex capabilities

  • Assay development or transfer, validation, and implementation
  • Prebuilt or custom Luminex assays
  • Integration with Precision’s other bioanalytical and specialty assays and technlogies
Specialty_QuartzBio

Resources related to protein and cytokine analysis 

Explore all resources

Additional cytokine and protein profiling services

  • Explore

    Western blotting

    Providing western blotting via automated platforms to ensure accurate, reproducible results
    Explore
  • Explore

    ELISA

    Services using the gold standard for quantitative antibody-based bioanalysis, with specialization in immunogenicity assay development
    Explore
  • Explore

    Olink Proteomics

    High-multiplex quantification of protein biomarkers with minimal clinical sample volume and exceptional sensitivity and specificity
    Explore

Explore the Precision blog

Read our blog to gain more insights and discover work that Precision has supported.

Read: The Immune System's Secret Language: Unlocking Cellular Communication The Immune System's Secret Language: Unlocking Cellular Communication

Translational Research - Lab Services

The Immune System's Secret Language: Unlocking Cellular Communication

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1754641583843, hs_published_at=1759436220388, description=Rob Maiale is a marketing strategist and creative technologist with 17 years of experience turning complex ideas into growth. He currently leads content strategy, where he transforms insights from Precision experts into market-shaping narratives that drive the advancement of next-generation therapies.  Rob’s career spans journalism, advertising, and brand storytelling, with a through-line of making the meaningful memorable. His work blends creative strategy with emerging AI tools to help Precision stay ahead of the curve—and above the noise., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/rob.png',altText='rob',fileId=194099000843}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, position=Associate Director, Digital Content & Inbound Marketing, job=, slug=rob-maiale, email=, hs_updated_by_user_id=78347666}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale

Discover
Read: How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development

Translational Research - Biomarkers - Oncology

How AI & Biomarkers Are Reshaping the Next Frontier in Drug Development

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1754641583843, hs_published_at=1759436220388, description=Rob Maiale is a marketing strategist and creative technologist with 17 years of experience turning complex ideas into growth. He currently leads content strategy, where he transforms insights from Precision experts into market-shaping narratives that drive the advancement of next-generation therapies.  Rob’s career spans journalism, advertising, and brand storytelling, with a through-line of making the meaningful memorable. His work blends creative strategy with emerging AI tools to help Precision stay ahead of the curve—and above the noise., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/rob.png',altText='rob',fileId=194099000843}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, position=Associate Director, Digital Content & Inbound Marketing, job=, slug=rob-maiale, email=, hs_updated_by_user_id=78347666}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale

Discover
Read: Mining for Gold? Prospecting Biospecimen Collections to Power Precision Medicine Mining for Gold? Prospecting Biospecimen Collections to Power Precision Medicine

Translational Research - Biospecimens

Mining for Gold? Prospecting Biospecimen Collections to Power Precision Medicine

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=193399854592, hs_child_table_id=0, hs_updated_at=1754641147525, hs_published_at=1759436220388, description=George Rogers is a scientific storyteller with over two decades of experience translating complex biology into content that connects. At Precision for Medicine, he facilitates scientific content development, crafting articles, case studies and presentations that spotlight the company’s integrated support for sponsors, from biomarker discovery and translational science to clinical trial execution and regulatory guidance. George’s background in cell analysis and drug development informs his ability to turn complex science into clear, compelling narratives that support business development and drive engagement across the life sciences landscape., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Geaorge-W-Rogers%2c-PhD-1.png',altText='Geaorge-W-Rogers,-PhD-1',fileId=194123711872}, lastname=Rogers, PhD, hs_initial_published_at=1753469768389, hs_created_by_user_id=26433386, hs_created_at=1753469702664, hs_is_edited=false, hs_deleted_at=0, name=George, job=Senior Manager, Scientific Content, slug=george-rogers-phd, hs_updated_by_user_id=78347666}, second={}, third={}})
  • George Rogers, PhD avatar

    George Rogers, PhD

Discover